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Abstract
Background: The Cochrane review on the effectiveness of speech and language therapy for aphasia following
stroke suggests intensity of therapy is a key predictor for outcome. Current aphasia services cannot provide
intervention at the intensity observed within trial contexts because of resource limitations. Telerehabilitation
could widen access to speech-language pathologists (SLPs) in geographically remote contexts and reduce the
time spent on travel by the therapist and patient. The current academic literature within this field is in its infancy,
with few trials of speech and language therapy (SLT) delivered by videoconference. Our pilot randomized controlled
trial (RCT) will explore feasibility aspects and effectiveness of telerehabilitation for aphasia in addition to standard SLT.
Method/design: Our study is a pragmatic, exploratory, pilot randomized controlled trial, where participants will be
randomized to a telerehabilitation group or a control group. Both groups receive standard SLT (usual care) but the
telerehabilitation group receives an additional 5 h of telerehabilitation per week over 4 weeks through videoconference.
This additional telerehabilitation focuses on spoken language with an emphasis on word naming. We aim to include 40
patients in each group, with inclusion criteria being aphasia any time post stroke. Participants will be assessed blindly at
pre-randomization (baseline), and 4 weeks and 4 months after randomization. The primary endpoint is naming ability 3
months after the completed intervention, measured by the Norwegian Basic Aphasia Assessment (NGA) naming subtest.
Secondary endpoints include other subtests of the NGA, the VAST (Verb and Sentence Test) subtest sentence production,
Communicative Effectiveness Index (CETI) and the Stroke and Aphasia Quality of Life scale (SAQOL-39). Experiences of
patients and SLPs with telerehabilitation are assessed using questionnaires and semi-structured interviews. Statistical
between group comparisons will be in line with an intention-to-treat analysis.
Discussion: This pilot RCT of intensive language training by videoconference will contribute new scientific evidence to
the field of aphasia telerehabilitation. Here, we describe our trial which will explore the feasibility of telerehabilitation for
aphasia as an intervention, our choice of primary and secondary outcome measures and proposed analyses. Our trial will
provide information for the development and delivery of future definitive RCTs.
Trial registration: ClinicalTrials.gov, ID: NCT02768922. Registered on 11 May 2016. Last updated on 17 November 2017.
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Background
Today, stroke stands as a major and leading cause of dis-
ability worldwide. Each year, one estimates that about
11,000 people in Norway acquire their first stroke [1]. In
Norway, stroke is the most common cause of disability
in the older population, with a stable incidence for the
last decade due to better preventive treatment and acute
management [1]. An aging European population in com-
bination with an improvement in the survival rates of
stroke is expected to put an increased burden on the
health care system in the years to come.
One of the most devastating consequences of stroke is
aphasia, a disturbance in language function which can
affect the ability to speak and includes difficulties with
speech production, auditory comprehension, as well as
reading and writing. It affects one third of stroke survi-
vors [2], where about 60% of the patients show consist-
ent communication impairment 1 year post stroke [3].
Aphasia impacts on the rehabilitation process, affecting
rehabilitation outcomes in a negative manner. The pres-
ence of aphasia following stroke is a negative predictor
for return to workforce [4]. People with aphasia report
significantly worse health-related quality of life (HRQL)
than stroke survivors without aphasia [5]. Hence, apha-
sia affects stroke survivors’ social life by isolating them
from social networks and limiting social participation
[6]. Furthermore, aphasia impacts on significant others,
describing third-party disability in family members [7].
Effective rehabilitation for aphasia is vital to recovery.
As the future holds an increasingly aged population,
the urgency to develop evidence-based, cost-effective in-
terventions to improve rehabilitation of people with
aphasia is profound [8]. The aim of aphasia rehabilita-
tion is an improvement in speech and language func-
tions, where speech and language therapy (SLT) is
considered to be “gold standard.” Several studies claim
that intensive SLT improves outcomes in aphasia [9–11].
The updated Cochrane review from 2016 on the effects
of SLT for aphasia following stroke, provides evidence of
the effectiveness of SLT in terms of improved functional
communication, reading, writing and expressive
language compared to no access to therapy [8]. This
meta-analysis furthermore concludes that there is
some evidence that therapy at high intensity, high
dose or over a longer period may be beneficial com-
pared to lower intensity, lower dose or over a shorter
period of time [8]. Today, a wide range of different
forms of therapy exists, from constraint-induced lan-
guage therapy (CILT) and functional-orientated ther-
apy to phonological, semantic and cognitive-linguistic
approaches. To date, the evidence for the best thera-
peutic approach, and details about timing, frequency,
duration, intensity and dose, is still unclear for the
overall aphasia population.
Access to SLT services, the recruitment and retention
of speech-language pathologists (SLPs) remains a prob-
lem worldwide [12]. In rural countries like Norway, pro-
viding tailored aphasia rehabilitation of sufficient
intensity and duration is a challenge. An early start to
rehabilitation, meeting the Norwegian national guide-
lines of ≥ 5 h of SLT per week [13], seems not to be pro-
vided for reasons as the lack of SLPs and a limited
capacity for aphasia services in the municipalities [14].
There is a unique opportunity to use telemedicine solu-
tions for providing therapy. Telerehabilitation represents
a future service delivery model for aphasia beyond the
traditional gold standard of “face-to-face” treatment [15].
Telerehabilitation has been defined as rehabilitation ser-
vices delivered via information and communication tech-
nology, and is categorized as rehabilitation services
provided at a distance [16, 17]. It has the potential to
widen the access to SLPs with promise of better and
more equitable services. However, the academic litera-
ture on aphasia telerehabilitation is yet in its infancy,
with substantial gaps in the scientific evidence of the
feasibility and effectiveness of this therapy approach.
This seems to be the case for stroke rehabilitation in
general, as a Cochrane review of all types of telerehabil-
itation services for stroke has concluded that there is
limited trials and evidence to guide practice [18]. Studies
of the use of videoconference in aphasia interventions is
especially lacking, with only one pilot RCT on the effect-
iveness of telerehabilitation by videoconference included
in the published Cochrane review on aphasia following
stroke [19]. Thus, the need to provide high-quality RCTs
to contribute scientific evidence and knowledge to this
relatively new field of aphasia research is a priority.
There are barriers and advantages with telerehabilita-
tion activities in SLT as elaborated in a recent review
[20]. A great advantage is higher availability of treatment
facilitating shorter waiting lists and reducing potential
delay of treatment. Telerehabilitation can reduce travel-
ing time and costs for both patient and therapist. As
treatment takes place in the patient’s home environment,
the rehabilitation can be goal orientated toward the pa-
tient’s everyday life, with greater involvement of family
and caregivers [20]. Telemedicine uses computer-based
technology, which might enable the use of interactive
computer-based therapy programs, videogames or social
media [21]. Following stroke, significant fatigue and
motor dysfunction can make traveling to receive therapy
a challenging task. By receiving therapy in the home, pa-
tients with fatigue can focus their energies on aphasia
rehabilitation rather than the journey to the rehabilita-
tion centre [15]. Favorable patient satisfaction with tele-
rehabilitation has been described [22, 23]. Despite these
advantages, there are several barriers that hinder the
routine implementation of telerehabilitation into a
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clinical setting. To date, we lack cost-benefit and cost-
effectiveness analyses on telerehabilitation. There are
ethical issues and threats to privacy and confidentiality
to address. The lack of infrastructure, technical and/or
personal support, funding of equipment and the lack of
reimbursement are other issues to consider [20].
We previously conducted a feasibility study to explore
the feasibility of delivering SLT by videoconference [24].
Tailored speech-language therapy was tested through
videoconference in four patients with aphasia. Patient
satisfaction and feasibility aspects were mapped through
logs, questionnaires and semi-structured interviews.
Aphasia rehabilitation via videoconference was found to
be acceptable to both patient and therapist, and consid-
ered sustainable and feasible with regards to technical,
logistic, patient and data safety aspects [24]. In this art-
icle we present the protocol of a pragmatic, exploratory,
pilot randomized controlled trial (RCT) of standard SLT
augmented by additional hours of SLT by videoconfer-
ence compared to standard SLT alone. This pilot trial
targets a larger, randomized sample size recruited across
a number of sites, providing a better understanding of
feasibility and new technical arrangements beyond our
earlier feasibility study.
Due to ethical issues we have chosen a design were we
compare the effects of aphasia telerehabilitation along-
side standard SLT (usual care) with standard SLT only.
To date, we have limited evidence of the effectiveness of
telerehabilitation, which limits the application of SLT via
videoconference as a treatment option.
Objectives and aims
The objective of this pragmatic exploratory pilot RCT is
to investigate the feasibility and effectiveness of speech
and language training by videoconference given in
addition to standard aphasia rehabilitation (usual care).
The primary and main aim of this study is to pilot the
RCT of the clinical effectiveness of augmented speech-
language therapy intervention for people with aphasia
after stroke delivered by videoconference over 4 weeks
(in addition to standard aphasia rehabilitation). We will
explore whether augmented speech-language therapy by
videoconference can improve word naming 4 months
post randomization, when compared to standard re-
habilitation (usual care).
Secondary aims of our pilot trial are to inform our
intervention content, delivery, technology as well as soft-
ware and training requirements. We will also gather data
to enhance our understanding of anticipated recruit-
ment, intervention adherence and dropout and future
sample size calculations and our choice of outcomes.
We also aim to explore the links between our interven-
tion and naming, functional communication, quality of
life and other language impairments than naming at 4
months post randomization, and whether it is sustain-
able and feasible with regards to ethical, technical, logis-
tic, patient and data safety aspects.
Methods/design
Design
The study will use a pragmatic prospective RCT design
(phase II exploratory trial), where outcomes will be com-
pared for people with aphasia post stroke, randomly al-
located to a telerehabilitation group or a control group.
The telerehabilitation group will receive 5-h speech-
language therapy via videoconference per week over 4
weeks, in addition to standard aphasia rehabilitation
(usual care). The control group will receive standard
speech-language therapy (usual care) only. The amount
of standard aphasia rehabilitation will be logged for all
participants. The patients will be assessed at inclusion
and before randomization (baseline), and at 4 weeks and
4 months post randomization. Testing will be blinded.
The protocol conforms to the Consolidated Standards of
Reporting Trials (CONSORT) guidelines for pragmatic
trials [25] and the guideline extensions for randomized
pilot and feasibility trials [26]. The trial design is
depicted by the flow diagram in Fig. 1. The timeline for
study enrollment, intervention and assessment is illus-
trated in Fig. 2 (Standard Protocol Items: Recommenda-
tions for Interventional Trials (SPIRIT) Figure). A
SPIRIT Checklist and CONSORT Checklist is included
as Additional files 1 and 2.
Ethics approval
The trial has been approved by the Norwegian Regional
Committee South East for Medical and Health Research
Ethics (reference number: 2015/2129, approval received
in December 2015).
Participants
We aim to recruit 80 participants with the diagnosis of
aphasia following stroke. The patients will be recruited
from the stroke units at Oslo University Hospital,
Akershus University Hospital, Østfold Hospital and
Bærum Hospital. Patients who are admitted for rehabili-
tation at Sunnaas Rehabilitation Hospital will also be in-
cluded. In addition, patients or those on the waiting list
at Sunnaas Rehabilitation Hospital will be invited to par-
ticipate. We will also seek to recruit patients from other
rehabilitation institutions, and in cooperation with
speech-language pathologists in the region of Oslo,
Østfold and Akershus. The recruitment of patients is
limited to these areas due to geographical and practical
aspects. Expressions of interest in participation will also
be invited from members of the Aphasia Association of
Norway (user organization).
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Inclusion criteria
Participants will be included if they meet the following
criteria:
 Patients with aphasia following stroke (any time post
stroke)
 Aphasia including naming impairment (percentile
score of 70 or lower on the Norwegian Basic Aphasia
Assessment (NGA) naming subtest)
 Norwegian as their main language
Exclusion criteria
Participants will be excluded from the study if they meet
any of the following criteria:
 Age below 16 years
 Patients who are unable to perform 5 h of speech-
language therapy per week due to medical (including
extensive hearing and/or vision impairment) or
cognitive reasons
 Patients who score > 70 percentile score on the NGA
naming subtest
 Patients with traumatic brain injury (TBI)
Patients with previous stroke are considered to meet
inclusion. Patients will be included regardless of whether
they are left or right handed. Regarding time post stroke,
no limits were set in order to ensure a valuable sample
size for this RCT, given the timeframe and geographical
set up for the recruitment. This will result in a less
homogenous sample, but increase ecological validity.
Procedures
Identification
Staff at recruitment sites will screen patients for eligibil-
ity, inform potential participants about the project and
refer them to Sunnaas Rehabilitation Hospital for further
investigation. Potential participants, who are patients at
Sunnaas Rehabilitation Hospital, will receive information
about the project and an invitation to take part in the
trial. Members of the Aphasia Association of Norway
Fig. 1 Flow diagram trial design
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will receive information about the study in a flyer and a
brochure inviting them to contact the research team if
they are interested in participating.
Screening for eligibility, baseline assessment and recruitment
Detailed information about the project will be provided
and the research investigator will seek informed consent
before carrying out baseline testing. The Informed
Consent Form and Information Sheet are accessible for
people with aphasia. Relatives and caretakers will be
carefully informed about participation. Eligibility will be
established by an ambulatory visit (HPO, IEW) to the
stroke unit, patient’s home or rehabilitation institution.
Their eligibility will be confirmed by using clinical obser-
vations, medical information and language tests. The
baseline assessment consists of the NGA subtests and
the Verb and Sentence Test (VAST) subtest sentence
production. If the potential participant is excluded, an
explanation that the project is not suitable for the pa-
tient will be given. The number of those screened, but
not included after screening, will be recorded along with
the reason for exclusion. When included in the project,
the participant’s demographic data will be collected in-
cluding age, gender, relationship status and housing con-
ditions. Relevant medical data, time post onset of stroke
and type and location of stroke will be charted. The
Modified Rankin Scale will describe the functional status
of the patients, and be registered at each assessment
time point (baseline, 4 weeks and 4 months; Fig. 1).
Participants will be contacted up to three times for par-
ticipation in outcome and follow-up assessment. No
further data will be collected for those who discontinue
study participation.
Randomization and allocation concealment
If found to meet the inclusion criteria participants will
be randomized directly after baseline assessment to the
telerehabilitation group or to the control group. A web-
based random sequence generator without limiting
conditions will generate the randomization sequence.
Fig. 2 Trial schedule of enrollment, intervention and assessment (Standard Protocol Items: Recommendations for Interventional Trials
(SPIRIT) Figure)
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The randomization sequence list will be created in ad-
vance of recruitment by an experienced scientist who is
not a member of the research team. Group allocation
will be obtained by phone (once baseline data has been
collected and recorded) from a member of staff who is
not involved in the study at the outpatient clinic at Sun-
naas Rehabilitation Hospital. Once the participant has
been randomized, the research investigator will inform
which group they have been allocated to. If the patient is
included in the intervention group, further arrangement
for the installation of the telerehabilitation equipment
and training in the use of the computer will be ad-
dressed. The participant, relatives and/or caregivers will
be given careful instructions on how to preserve alloca-
tion concealment in the 4-week control and follow-up
testing, including instructions not to discuss treatment
with the blinded SLPs.
Blinding
Neither the participant nor the SLPs performing the
therapy are blinded to treatment allocation due to the
nature of the intervention. However, baseline assessment
will be blinded as it will be performed before group allo-
cation. The 4-week control and follow-up testing will be
performed by external SLPs blinded to group allocation.
All data collection sessions will be audio and video
taped. In cases where allocation is inadvertently revealed
by the patient, relatives and/or caregivers during conver-
sation or by other means, a second SLP blinded to treat-




The primary endpoint of this study is naming ability 4
month post randomization, measured by the subtest
“naming” in the NGA. The minimum difference of 8
percentile score is considered clinically significant. For
the assessment of language functioning, the NGA [27]
with the subtests comprehension, naming and repetition
is included in the test battery. Percentile scores (i.e., per-
centile rank compared to the norm material of the
NGA) will be used because they – for all severity levels
of aphasia – mirror clinically relevant progression more
accurately than raw scores.
Key secondary endpoint(s)
Key secondary endpoints are other language functions 4
months post randomization measured by the NGA sub-
test “comprehension” and “repetition.” In addition, the
VAST subtest sentence production [28], assesses the
ability of verb and sentence production beyond words.
Functional communication is assessed using the
Communicative Effectiveness Index (CETI) [29]. These
endpoints are scored/collected immediately after the
intervention (4 weeks) and at the 4-month post
randomization follow-up to detect any extended effect
of the intervention.
Other secondary endpoints
Quality of life will be assessed by using the Stroke and
Aphasia Quality of Life scale (SAQOL-39) [30]. The
SAQOL-39 is a quality of life scale developed specifically
with regard to persons with aphasia. In addition, the ex-
periences of patients, relatives and therapists with the
telerehabilitation services and their participation within
the trial will be gathered using questionnaires and semi-
structured interviews with both SLPs and selected par-
ticipants. Adverse events, including technical challenges,
will be logged.
Intervention
Control group (usual care)
The control group will receive usual care provided by
SLPs at the community level or in rehabilitation institu-
tions. As usual care varies in the different municipalities
and institutions, both in terms of type and frequency,
the services provided for each participant will depend on
the local resources available. The therapy may include
face-to-face SLT in a single session or by group. The
dose of therapy received from inclusion to follow-up 4
months post randomization will be recorded. Partici-
pants who are randomized to the control group will not
receive any project specific intervention, but will, at the
4-month post-randomization follow-up, i.e., after their
study participation, be referred for participation in an in-
tensive language training program at Sunnaas Rehabilita-
tion Hospital.
Telerehabilitation group
As current scientific evidence favors intensity in aphasia
interventions, our trial will offer a high-intensity therapy.
Because there still is uncertainty about the best therapy
approach within aphasia rehabilitation, no specific ap-
proach or theory has been chosen for our intervention
beyond tasks that can enhance functional expressive
communication. In the intervention group, the partici-
pants will receive augmented language training of 5 h a
week over four consecutive weeks. This will be in
addition to any usual SLT the participant is already re-
ceiving. The aim is to give 1 h SLT via videoconference
per day, 5 days per week, but this can be adjusted to the
participant’s timetable and rehabilitation schedule if ne-
cessary. Participants with ≥ 16 sessions over 32 days are
considered to be per protocol. The SLT will be per-
formed by an SLP using videoconference via the Internet
from Sunnaas Rehabilitation Hospital to the laptop in
the patient’s home, or rehabilitation/nursing ward. To
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secure treatment fidelity and replication for future stud-
ies and transparency of reporting, we have used the
Template for intervention Description and Replication
(TIDieR) Checklist and Guide (Additional file 3 [31]), to
record and describe the intervention delivered by video-
conference. The main features of the intervention using
TIDier are illustrated in Table 1.
The SLT delivered by videoconference will be tailored
to the participant’s language impairment. We will work
on all language modalities; however, the intervention will
have an emphasis on oral naming and speech produc-
tion. As the therapy will be individualized, there will be
a broad range of tasks including word production in
“natural” sequences (e.g., weekdays and months), picture
naming, discussion about familiar topics (e.g., hobbies
and family) and conversations about a concrete subject,
picture or situation. Since the main focus is expressive
speech, material stimulating everyday communication
will be the first choice and this will be tailored to the in-
dividual participant’s needs and goals. Material used in
the intervention includes Norwegian versions of the
Newcastle University Aphasia Therapy Resources
(NUMA) [32–34], a collection of SLP-made tasks for
aphasia compiled as Sareptas afasikrukke [35] and for
some patients Lexia, a computer-based training pro-
gram. In addition, text and pictures from the Internet,
such as the easy to read newspaper Klar Tale, may be
used if applicable. The SLPs in our trial will receive
training in how to use the chosen material within the
context of a clinical trial and computer software to pro-
vide the intervention by videoconference.
The broad range of material accessible to the interven-
tion gives the therapist an optimal setting to tailor the
therapy to the patient’s impairment level. The therapy
will be in line with patient’s own goals, where a
personalization of the therapy is considered a key of suc-
cess with regards to compliance to protocol. Because the
patients continue to receive ongoing care, we expect a
wide range of variation of usual care with regards to type
of therapy and the intensity with which it is given. Usual
care will reflect upon rehabilitation resources available.
To account for this expected heterogeneity, careful rec-
ord of the usual care provided and accessed will be com-
pleted for all participants.
Fidelity
For each participant in the intervention group, a report
will be written. The report will describe the tailored
therapy that each participant has received via videocon-
ference. The content of the reports will be compared
through regular fidelity reviews with the intervention de-
scription in the trial protocol.
Technical solutions
As already tested in our feasibility study [24], we will use
videoconference software and equipment installed at
Sunnaas Rehabilitation Hospital and in study laptops
given to the participants. The videoconference software
is delivered by the “Norwegian Health Net (NHN),” a
company owned by the Ministry of Health and Care ser-
vices. Videoconference is provided through encrypted
software which meets requirements with regards to data
safety aspects, privacy and confidentiality. As the therapy
sessions are live, there are no recordings or storage of
video, sound or picture. The software we will use for the
videoconference is Cisco Jabber/ Acano. In addition, the
SLPs will also use the software called LogMeIn which al-
lows the therapist to remotely control the participant’s
computer, and has been shown to be a valuable tool in
delivering therapy and assistance should technical prob-
lems arise [24].
Our current technical setup builds upon experience
from the feasibility study “Language training straight
home” [24]. In this former feasibility study some areas
for improvement were identified which have been inte-
grated in the present protocol. To maintain safety as-
pects a checklist has been implemented to be used at
the start of each therapy session to control and adjust
the patient’s physical environment. This is to ensure op-
timal training conditions, preserve accurate procedures
in case of emergency and to accommodate privacy is-
sues. When it comes to the technical aspects of deliver-
ing aphasia rehabilitation by videoconference, one
Table 1 The intervention illustrated by main features from the
Template for intervention Description and Replication (TIDieR)
Checklist and Guide
Brief name: Intensive speech and language therapy by videoconference
Why: To improve expressive language function in patients with aphasia
after stroke
What: Intensive speech and language therapy with an emphasis on
naming. The therapy will be tailored to the participant’s language
impairment level and focus on expressive language and everyday
communication. Material used in the training will include the Newcastle
University Aphasia Therapy Resources (NUMA), a collection of SLP-made
tasks for aphasia compiled as Sareptas afasikrukke and Lexia (computer-
based training program). In addition, text and pictures from the Internet
may also be used
Who provided: Speech and language pathologists sited at Sunnaas
Rehabilitation Hospital. Speech-language pathologists (SLPs) will receive
training in how to give intervention by videoconference within the
context of a clinical trial
How: Using videoconference and remote control software to a laptop
at the patient’s location
Where: From Sunnaas Rehabilitation Hospital to the patient’s home or
institution, e.g., rehabilitation ward or nursing home
When/How much: The experimental intervention consists of 5 h of
speech and language therapy a week, over 4 weeks (total dose of 20 h
of therapy). Participants with ≥ 16 sessions over 32 days will be
considered to be per protocol
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expects to encounter technical challenges not revealed
during the small feasibility study (n = 4). A separate log
to map technical error has been developed and inte-
grated into the protocol. Furthermore, the technical so-
lutions tested in the feasibility study have been improved
compared to the original technical setup. This includes a
separate speaker to improve sound quality and a wide-
angle web camera to enable the therapist to see the
patient’s upper body in case alternative communication
approaches, such as the use of body language and/or
gestures, are needed.
Sample size
No large RCTs have been carried out within the field of
aphasia telerehabilitation, especially with the use of
videoconference SLT. Previous studies have used inter-
ventions not applicable with the current protocol, and
have been of varying quality and used small sample sizes.
We were, therefore, unable to calculate an a prior accur-
ate sample size. Thus, our pilot RCT will support a more
accurate sample size estimate and to inform a definitive
trial of the effect of intensive telerehabilitation for apha-
sia. We will investigate possible effects using the per-
centile score of the NGA naming subtest where we
consider the minimal clinically meaningful effect to be
an improvement of 8 percentile scores. Given a standard
deviation of 18.17 (based on recently collected data from
another project without telerehabilitation), 32 partici-
pants will be sufficient to detect a significant improve-
ment within a group between time points using a
pairwise comparison, with a significance level of 5 and a
power of 80. This will enable the study to make some
suggestions on effectivity. Considering possible drop-
outs, the study aims to include 40 participants in each
group, with a total number of 80 subjects. We anticipate
that results from this pilot RCT will yield data to inform
a more accurate sample size calculation for future defini-
tive RCTs.
Statistical analysis
Data will be analyzed on an intention-to-treat basis. De-
scriptive statistics will be applied and the characteristics
of the sample will be described. The trial is a longitu-
dinal study with continuous repeated measurements.
The data will be analyzed by using mixed models. A
mixed model is preferred to the more traditional re-
peated measures analysis of variance (ANOVA) because
of its advantages in the way in which it accommodates
missing values. Data will be examined for differences
over time and between groups. Subgroup analysis will be
performed to explore factors considered to affect the
outcome of the trial like differences in time since onset
of stroke or demographic and stroke-related factors.
Qualitative data collected from semi-structured
interviews will be suitably coded for qualitative re-
sponses to be categorized and examined.
Discussion
This protocol describes a pragmatic, pilot randomized
controlled trial (phase II exploratory trial) that should
make a valuable contribution to the field of aphasia
telerehabilitation.
This trial’s objective is to investigate the feasibility and
effectiveness of augmented SLT delivered via videocon-
ference in addition to the standard SLT that the partici-
pants are already receiving. To our knowledge, there are
no RCTs of this size that have explored the use of video-
conferencing in providing an augmented, intensive SLT
intervention for aphasia after stroke.
Our trial will look at the feasibility of scaling the inter-
vention up for a larger trial and clinical implementation.
Future studies may draw upon our findings if the trial is
shown to be feasible, not harmful and indicates effects
to be explored beyond this pilot. Our trial might offer
some insight into videoconferencing as an effective
mode of delivering speech and language interventions in
the rehabilitation of people with aphasia, as we have
chosen also to investigate clinically meaningful improve-
ment. The trial does not meet sample size based on our
assumptions for power calculation; however, large effect
sizes might result in significant effects possibly influen-
cing clinical practice. The main purpose of the study,
however, is to contribute to the development of future
fully powered definitive trials on the effectiveness of this
therapy approach, also compared to – and not only in
addition to – standard care.
A recent review of the effectiveness of SLT for post-
stroke aphasia [8] suggests that intensity may be a key
predictor for outcome. This trial investigates the feasibil-
ity of telerehabilitation as a supplement to increase the
intensity of therapy within aphasia services with limited
resources amongst a patient population with common
mobility problems and fatigue within a geographically
remote context. If telerehabilitation can be used within
such a setting, our trial may demonstrate potential for
change in future practice. Future studies examining SLT
via videoconference as an alternative to usual care will
be informed by this study. By shedding light on feasibil-
ity aspects through the data gathered using qualitative
research methods and logs to map technical errors, we
will expect to develop a greater understanding of SLT via
videoconference.
When it comes to evaluate the feasibility of telereh-
abilitation for aphasia, broad participant inclusion
criteria in this trial may be regarded as strength. Recent
evidence suggests that there may be an interaction be-
tween timing post stroke and tolerance of high-intensity
SLT [8]. By including participants at all stages of aphasia,
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from acute to chronic, the data will be more clinically
representative for evaluating feasibility features, and of
greater ecological validity to the population of people
with aphasia. This trial is pragmatic in nature, and due
to ecological validity, practicability and ethical issues, we
have chosen to examine the effect of additional aphasia
telerehabilitation alongside standard SLT in comparison
to standard SLT only. As telerehabilitation is relatively
new to the field of aphasia research and there is limited
pre-existing evidence for the primary and secondary out-
comes of our trial, it is considered unethical to prevent
the patients from receiving usual care. Thus, an added
benefit of this design is to reassure potential participants
that randomization may augment their access to therapy
and not restrict it.
Trial status
Recruitment of patients started in May 2016, and 50 partic-
ipants have been recruited and randomized into the trial.
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